| Use of herbal medicine by pregnant women: What physicians need to know SM Illamola, OU Amaeze, LV Krepkova, AK Birnbaum, A Karanam, ... Frontiers in pharmacology 10, 1483, 2020 | 97 | 2020 |
| Inclusion of pregnant and breastfeeding women in research–efforts and initiatives SM Illamola, C Bucci‐Rechtweg, MM Costantine, E Tsilou, CM Sherwin, ... British Journal of Clinical Pharmacology 84 (2), 215-222, 2018 | 57 | 2018 |
| Challenges regarding analysis of unbound fraction of highly bound protein antiretroviral drugs in several biological matrices: lack of harmonisation and guidelines SM Illamola, D Hirt, JM Tréluyer, S Urien, S Benaboud Drug Discovery Today 20 (4), 466-474, 2015 | 29 | 2015 |
| Approaches to handling missing or “problematic” pharmacology data: Pharmacokinetics DJ Irby, ME Ibrahim, AM Dauki, MA Badawi, SM Illamola, M Chen, ... CPT: pharmacometrics & systems pharmacology 10 (4), 291-308, 2021 | 23 | 2021 |
| Population pharmacokinetics of amikacin in adult patients with cystic fibrosis SM Illamola, HQ Huynh, X Liu, ZN Bhakta, CM Sherwin, TG Liou, ... Antimicrobial agents and chemotherapy 62 (10), 10.1128/aac. 00877-18, 2018 | 20 | 2018 |
| Determination of total and unbound concentrations of lopinavir in plasma using liquid chromatography–tandem mass spectrometry and ultrafiltration methods SM Illamola, L Labat, S Benaboud, R Tubiana, J Warszawski, JM Tréluyer, ... Journal of Chromatography B 965, 216-223, 2014 | 20 | 2014 |
| Emtricitabine seminal plasma and blood plasma population pharmacokinetics in HIV-infected men in the EVARIST ANRS-EP 49 study E Valade, JM Tréluyer, SM Illamola, N Bouazza, F Foissac, ... Antimicrobial agents and chemotherapy 59 (11), 6800-6806, 2015 | 19 | 2015 |
| Population approach to analyze the pharmacokinetics of free and total lopinavir in HIV-infected pregnant women and consequences for dose adjustment F Fauchet, JM Treluyer, SM Illamola, C Pressiat, G Lui, E Valade, ... Antimicrobial agents and chemotherapy 59 (9), 5727-5735, 2015 | 19 | 2015 |
| Development and validation of a LC–MS/MS method for the quantification of tenofovir and emtricitabine in seminal plasma SM Illamola, E Valade, D Hirt, E Dulioust, Y Zheng, JP Wolf, JM Tréluyer Journal of Chromatography B 1033, 234-241, 2016 | 17 | 2016 |
| Clinical pharmacokinetics of amikacin in pediatric patients: a comprehensive review of population pharmacokinetic analyses SM Illamola, CM Sherwin, JGC van Hasselt Clinical Pharmacokinetics 57 (10), 1217-1228, 2018 | 16 | 2018 |
| Evaluating renal function and age as predictors of amikacin clearance in neonates: model‐based analysis and optimal dosing strategies SM Illamola, H Colom, JGC van Hasselt British Journal of Clinical Pharmacology 82 (3), 793-805, 2016 | 16 | 2016 |
| Vinpocetine, cognition, and epilepsy KJ Meador, B Leeman-Markowski, AE Medina, SM Illamola, J Seliger, ... Epilepsy & Behavior 119, 107988, 2021 | 13 | 2021 |
| Severity of topiramate‐related working memory impairment is modulated by plasma concentration and working memory capacity SP Callisto, SM Illamola, AK Birnbaum, CM Barkley, SPR Bathena, ... The Journal of Clinical Pharmacology 60 (9), 1166-1176, 2020 | 12 | 2020 |
| Are prophylactic and therapeutic target concentrations different?: the case of lopinavir-ritonavir or lamivudine administered to infants for prevention of mother-to-child HIV-1 … F Foissac, J Blume, JM Tréluyer, T Tylleskär, C Kankasa, N Meda, ... Antimicrobial agents and chemotherapy 61 (2), 10.1128/aac. 01869-16, 2017 | 10 | 2017 |
| Population pharmacokinetic modeling of tenofovir in the genital tract of male HIV-infected patients E Valade, N Bouazza, G Lui, SM Illamola, S Benaboud, JM Treluyer, ... Antimicrobial agents and chemotherapy 61 (3), 10.1128/aac. 02062-16, 2017 | 8 | 2017 |
| Generic drug products in paediatrics: Where are the data? SM Illamola, AK Birnbaum, CM Sherwin British Journal of Clinical Pharmacology 85 (9), 1871, 2019 | 5 | 2019 |
| Development and validation of a UPLC-UV method for the quantification of thiopurine methyltransferase enzyme activity in human erythrocytes SM Illamola, AK Echaabi, C Mazeron, S Deshayes, MA Loriot, N Pallet Journal of Chromatography B 1113, 91-97, 2019 | 5 | 2019 |
| Busulfan dose recommendation in inherited metabolic disorders: population pharmacokinetic analysis T Takahashi, SM Illamola, CA Jennissen, SE Long, TC Lund, PJ Orchard, ... Transplantation and Cellular Therapy 28 (2), 104. e1-104. e7, 2022 | 4 | 2022 |
| Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients SCM Job KM, Roberts JK, Enioutina EY, Illamola SM, Kumar SS, Rashid J, Ward ... Expert Opin Drug Metab Toxicol 7 (17), 747-765, 2021 | 2* | 2021 |
| Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends X Lyu, SM Illamola, SE Marino, IE Leppik, S Dahmer, P Lehfeldt, ... Current Therapeutic Research 99, 100709, 2023 | | 2023 |
